Unveiling Econometric Approaches in Patent Valuation

When most people think about valuing a patent, they instinctively think about accountants, auditors, and financial spreadsheets. But there is another, less visible approach that economists have developed over decades – one that does not look at the patent in isolation but instead reads the signals embedded in stock market movements and renewal fee decisions. These are econometric methods of patent valuation: data-driven, statistically rigorous, and capable of revealing insights about patent value that no balance sheet can capture on its own.

What econometric methods actually do
Stock market valuation approach
Tobin’s q and patent citations
Event studies and stock price reactions
Limitations of the stock market approach
Patent renewal data approach
The Pakes-Schankerman model
What renewal data can and cannot tell us
Combining both approaches: what the evidence tells us
Why Indian professionals should care

What econometric methods actually do

Econometric valuation uses statistical models to extract information about patent value from observable economic behaviour – things like how a firm’s share price reacts when a patent is granted, or whether a patentee continues paying annual renewal fees. Rather than directly assigning a rupee figure to a single patent, these methods typically work at an aggregate level, estimating the distribution of patent values across a portfolio or across an industry. As Pitkethly (2006) observed, most econometric studies focus on aggregate patent values rather than individual patents, reflecting the practical difficulty of firm-level case studies given commercial sensitivity.

There are two main streams of econometric work on patent valuation: the stock market valuation approach and the patent renewal data approach. Both treat patent value as something revealed indirectly through observed decisions – by investors and by patentees respectively.

Stock market valuation approach

The central idea here is straightforward: if a firm’s patents have economic value, that value should be reflected in how the market prices the firm’s shares. Investors, in theory, incorporate all available information – including a firm’s patent holdings – when deciding what a company is worth. Economists exploit this by running regression analyses that link a firm’s market value to its patent stock and patent characteristics.

Tobin’s q and patent citations

The most influential work in this stream is the landmark study by Hall, Jaffe, and Trajtenberg (2005), which used data from over 4,800 US manufacturing firms spanning 1963 to 1995. They estimated what economists call a Tobin’s q equation – essentially a ratio comparing a firm’s market value to the replacement cost of its assets – and tested whether patent-related variables explained deviations from that baseline. Their finding was striking: each additional citation received per patent was associated with a roughly 3% increase in the firm’s market value. Citation-weighted patent stocks turned out to be more strongly correlated with market value than simple patent counts alone.

This result has significant practical meaning. It tells us that the stock market is not merely rewarding firms for holding patents – it is rewarding them for holding important patents, as evidenced by how often those patents are cited by later inventors. A patent that others build upon is one the market recognises as genuinely valuable intangible capital.

Event studies and stock price reactions

A more targeted econometric tool within this approach is the event study. Here, researchers measure the abnormal change in a firm’s share price on the day a patent is granted (or another patent-related event occurs), after stripping out broader market movements. Pakes (1985) examined stock market returns for 120 firms between 1968 and 1975 and found that an unexpected new patent was associated with an average increase of around $810,000 in a firm’s market value. Later studies by Kogan et al. (2017) extended this across millions of US patents from 1926 to 2010, using stock price reactions on grant dates to construct value-weighted innovation indices that proved strongly correlated with firm growth and aggregate economic output.

Event study methodology is particularly useful in high-stakes sectors like pharmaceuticals, where a court ruling on a patent dispute or the entry of a generic competitor can be traced precisely to its impact on a firm’s valuation. The measured abnormal return is the market’s own estimate of what that patent event was worth – making it arguably the most market-authentic measure of patent value available.

Limitations of the stock market approach

The stock market approach has real constraints. It can only be applied to publicly listed companies – which immediately excludes the vast majority of Indian firms, especially startups, MSMEs, and research institutions that hold valuable patents but are not traded on BSE or NSE. Moreover, a firm’s market value is shaped by dozens of factors unrelated to its patents: management quality, macroeconomic sentiment, sectoral trends. Isolating the patent-specific contribution requires careful statistical controls, and even then there is always residual noise. Additionally, this method captures patent value only in aggregate at the firm level; it cannot reliably distinguish the value of one patent from another within the same portfolio.

Patent renewal data approach

The second stream of econometric work takes a completely different vantage point: it looks at the patentee’s own behaviour rather than the market’s. The logic is elegant and grounded in revealed preference theory. In India, as in most jurisdictions, a patent must be renewed annually by paying escalating maintenance fees to the Indian Patent Office. A patentee who pays the renewal fee is effectively declaring that the patent’s value to them exceeds its cost of upkeep. A patentee who lets a patent lapse is revealing the opposite.

The Pakes-Schankerman model

The foundational econometric framework here was developed by Pakes and Schankerman (1984, 1986). Their model treats patent value as a stream of annual returns that depreciates over time, and uses the observed pattern of renewal decisions across a large population of patents to estimate the underlying distribution of initial patent values. The core insight is that a patentee renews only when the expected return from holding the patent for one more year exceeds the renewal fee. Since fees increase with patent age, a patent that survives longer reveals a higher initial value. Bessen (2008) confirmed that patents with longer renewal lives demonstrably hold higher economic value, and this finding has been replicated across multiple jurisdictions.

Importantly for Indian students of IP management, this methodology has been directly applied to Indian patent data. Danish, Ranjan, and Sharma (2020) applied the renewal model to patents granted by the Indian Patent Office and found that patent value distribution in India is highly asymmetric: the large majority of patents hold negligible economic value, while a small subset commands substantially higher worth. They also found meaningful variation across technology sectors – patents in instruments, mechanical, and electrical fields tended to be more valuable than those in chemical and pharmaceutical sectors, a finding with direct strategic implications for Indian firms deciding where to concentrate their patenting efforts.

What renewal data can and cannot tell us

The renewal approach has the crucial advantage of focusing on the patent itself rather than the firm, making it more directly relevant for valuing individual patents or portfolios. As Pitkethly (1997) noted, because the patentee typically has more information about the patent’s prospects than an outside investor, renewal decisions may actually be a more accurate signal of the patent’s intrinsic value than stock market movements. The patentee is not guessing – they are making an informed business decision with their own money.

However, renewal data has important limitations. It is inherently retrospective – it can only be measured after the fact, and often only in aggregate across many patents, not for a single patent in isolation. There is also potential for systematic bias: internal organisational pressures may lead firms to renew patents conservatively (undervaluing some) or to maintain patents for strategic blocking purposes even when commercial returns are marginal (overvaluing others relative to true economic use). Furthermore, renewal fees themselves are typically quite low relative to the actual value at stake, meaning the threshold for renewal is a blunt instrument.

Combining both approaches: what the evidence tells us

The most robust picture of aggregate patent value emerges when both approaches are used together. Studies like Lanjouw, Pakes, and Putnam (1998) demonstrated how patent application data and renewal records can be combined to better characterise the full lifecycle value of patents across countries. The convergence of findings across methods – stock market and renewal data – on the skewed distribution of patent values (few patents are worth a great deal; most are worth very little) is one of the most robust empirical regularities in the economics of innovation.

For IP managers and legal practitioners working in India, this has direct operational significance. It means that a firm holding 200 patents should not assume uniform value across its portfolio. Econometric signals – which patents are being heavily cited, which are being renewed to full term, how the market reacted when key patents were granted – can help prioritise which assets deserve active commercialisation, licensing efforts, or enforcement, and which are better allowed to lapse.

Why Indian professionals should care

India’s patent filing numbers have grown substantially over the past two decades. But as academic research on Indian patent data consistently shows, filing volume does not equal value. Econometric methods provide the tools to move beyond counting patents to actually understanding what those patents are worth – and to make smarter decisions about prosecution, renewal, licensing, and litigation strategy. For law students and IP professionals, familiarity with these methods is increasingly important not just for academic purposes but for advising clients in an era where intangible assets increasingly drive firm value and investor expectations.

The European Commission’s review of patent valuation methodologies identifies both the market value approach and the renewal approach as the two primary academic frameworks for understanding what patents are worth – and notes that both reveal the same fundamental truth: patent value is heterogeneous, uncertain, and far better understood through data than through intuition alone.

What do you think? Given that most Indian patent holders are not publicly listed companies, should renewal data analysis be made more accessible through mandatory publication of lapse and renewal records by the Indian Patent Office? And if stock market valuation already signals the importance of patent quality over mere patent quantity, what does that imply for how Indian firms should be strategically managing their R&D and filing decisions?

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

References

PDF 📄

Table of Contents

What econometric methods actually do 🔗

Stock market valuation approach 🔗

Tobin’s q and patent citations 🔗

Event studies and stock price reactions 🔗

Limitations of the stock market approach 🔗

Patent renewal data approach 🔗

The Pakes-Schankerman model 🔗

What renewal data can and cannot tell us 🔗

Combining both approaches: what the evidence tells us 🔗

Why Indian professionals should care 🔗